We first looked at CA9, a ccRCC diagnostic marker present only in tumor cells61 that is differentially expressed in scRNA-seq subtype 1 compared to subtypes 2 and 3 (Figure 6F). This evidence concerns the gene CA9 and nonpapillary renal cell carcinoma.